Pacira BioSciences Inc (PCRX)
17.40
+0.36
(+2.14%)
USD |
NASDAQ |
Nov 21, 16:00
17.40
0.00 (0.00%)
After-Hours: 20:00
Pacira BioSciences Price to Book Value: 1.071 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.049 |
| November 19, 2024 | 1.030 |
| November 18, 2024 | 1.025 |
| November 15, 2024 | 1.022 |
| November 14, 2024 | 1.008 |
| November 13, 2024 | 1.013 |
| November 12, 2024 | 1.035 |
| November 11, 2024 | 1.078 |
| November 08, 2024 | 1.062 |
| November 07, 2024 | 1.090 |
| November 06, 2024 | 1.088 |
| November 05, 2024 | 1.064 |
| November 04, 2024 | 1.013 |
| November 01, 2024 | 1.021 |
| October 31, 2024 | 1.022 |
| October 30, 2024 | 1.039 |
| October 29, 2024 | 1.058 |
| October 28, 2024 | 1.055 |
| October 25, 2024 | 1.036 |
| October 24, 2024 | 1.048 |
| October 23, 2024 | 1.07 |
| October 22, 2024 | 1.085 |
| October 21, 2024 | 1.067 |
| October 18, 2024 | 1.077 |
| October 17, 2024 | 1.044 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.024 |
| October 15, 2024 | 1.028 |
| October 14, 2024 | 1.005 |
| October 11, 2024 | 0.9986 |
| October 10, 2024 | 0.9549 |
| October 09, 2024 | 0.9592 |
| October 08, 2024 | 0.9641 |
| October 07, 2024 | 0.9844 |
| October 04, 2024 | 1.017 |
| October 03, 2024 | 0.9783 |
| October 02, 2024 | 0.9561 |
| October 01, 2024 | 0.9419 |
| September 30, 2024 | 0.9266 |
| September 27, 2024 | 0.7628 |
| September 26, 2024 | 0.7518 |
| September 25, 2024 | 0.7297 |
| September 24, 2024 | 0.7481 |
| September 23, 2024 | 0.7491 |
| September 20, 2024 | 0.7622 |
| September 19, 2024 | 0.7706 |
| September 18, 2024 | 0.7685 |
| September 17, 2024 | 0.7525 |
| September 16, 2024 | 0.7077 |
| September 13, 2024 | 0.6878 |
| September 12, 2024 | 0.6678 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6138
Minimum
Aug 09 2024
6.938
Maximum
Sep 02 2020
3.336
Average
3.479
Median
Price to Book Value Benchmarks
| Cyclo Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
| PS Ratio | 1.363 |
| Price to Free Cash Flow | 4.893 |
| Price | 17.40 |
| Earnings Yield | -11.56% |
| Market Cap | 803.18M |
| Operating PE Ratio | 9.283 |
| Normalized PE Ratio | 24.40 |